McKesson Applauds DOJ Policy Change on Opioid Quotas

16:19 EDT 12 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Company previously called for revisions to production quota McKesson Corporation today praised the U.S. Department of Justice’s decision to exercise its authority to reduce opioid production if the agency believes a partic...

Other Sources for this Article

McKesson Corporation
April Marks, 415-732-1384


More From BioPortfolio on "McKesson Applauds DOJ Policy Change on Opioid Quotas"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...